Zydus Lifesciences Limited (NSE: ZYDUSLIFE)
India
· Delayed Price · Currency is INR
949.05
+5.00 (0.53%)
Nov 22, 2024, 3:30 PM IST
Zydus Lifesciences Revenue
Zydus Lifesciences had revenue of 52.37B INR in the quarter ending September 30, 2024, with 19.87% growth. This brings the company's revenue in the last twelve months to 214.84B, up 14.42% year-over-year. In the fiscal year ending March 31, 2024, Zydus Lifesciences had annual revenue of 195.47B with 13.40% growth.
Revenue (ttm)
214.84B
Revenue Growth
+14.42%
P/S Ratio
4.46
Revenue / Employee
7.98M
Employees
26,921
Market Cap
954.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 195.47B | 23.10B | 13.40% |
Mar 31, 2023 | 172.37B | 21.28B | 14.08% |
Mar 31, 2022 | 151.10B | 7.06B | 4.90% |
Mar 31, 2021 | 144.04B | 1.50B | 1.06% |
Mar 31, 2020 | 142.53B | 10.88B | 8.26% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionZydus Lifesciences News
- 5 days ago - Zydus Lifesciences faces setback as SC denies interim relief in breast cancer drug case, sends matter back to Delhi HC - Business Upturn
- 10 days ago - Zydus Lifesciences’s market cap gains Rs 1,363 crore as stock surges 1.43% - Business Upturn
- 10 days ago - Zydus Lifesciences Ltd (BOM:532321) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ... - GuruFocus
- 11 days ago - Zydus Lifesciences stock drops 2% on Q2 results - Business Upturn
- 11 days ago - Zydus Lifesciences Q2 FY25: Revenue up 20% YoY to Rs 5237 crore, Net Profit up 13.7% YoY - Business Upturn
- 12 days ago - Q2 results today: Hyundai Motor India, Bosch, Zydus Lifesciences, Nykaa, Unno Minda, 3M India, Natco Pharma, TBO Tek among companies to announce earnings - Business Upturn
- 4 weeks ago - Zydus Lifesciences receives WHO approval for ZyVac® TCV, making it eligible for UN procurement - Business Upturn
- 5 weeks ago - Zydus Lifesciences gets USFDA approval for Fludrocortisone Acetate tablets - Business Upturn